Redefining primary hyperaldosteronism as “The Syndrome of Inappropriate Aldosterone Secretion (SIALDS)”: A common but unrecognized cause of hypertension

Screening for Primary Aldosteronism Among Hypertensive Adults with Obstructive Sleep Apnea: A Retrospective Population-Based Study

(2023) Gregory L Hundemer et al.   AMERICAN JOURNAL OF HYPERTENSION

Biomarkers to Guide Medical Therapy in Primary Aldosteronism

(2023) Gregory L Hundemer et al.   ENDOCRINE REVIEWS

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

(2022) Mason W. Freeman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correction: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial

(2022) Nathan R. Hill et al.   Trials

Primary Aldosteronism

(2021) John W. Funder   HYPERTENSION

Performance of the Aldosterone-to-Renin Ratio as a Screening Test for Primary Aldosteronism: A Systematic Review and Meta-Analysis

(2021) Annie Hung et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study

(2021) Gregory L. Hundemer et al.   HYPERTENSION

The Unrecognized Prevalence of Primary Aldosteronism

(2020) Jenifer M. Brown et al.   ANNALS OF INTERNAL MEDICINE

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

(2020) George L. Bakris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism

(2020) Nicholas Yozamp et al.   HYPERTENSION

Long‐term BP control and vascular health in patients with hyperaldosteronism treated with low‐dose, amiloride‐based therapy

(2019) Joseph L. Izzo et al.   Journal of Clinical Hypertension

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

(2018) Bryan Williams et al.   Lancet Diabetes & Endocrinology

Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis

(2018) Silvia Monticone et al.   Lancet Diabetes & Endocrinology

Continuum of Renin-Independent Aldosteronism in NormotensionNovelty and Significance

(2017) Rene Baudrand et al.   HYPERTENSION

Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity

(2017) Gregory L. Hundemer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice

(2017) Silvia Monticone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Study Heterogeneity and Estimation of Prevalence of Primary Aldosteronism: A Systematic Review and Meta-Regression Analysis

(2016) Sabine C. Käyser et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline

(2016) John W. Funder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial

(2016) Morris J Brown et al.   Lancet Diabetes & Endocrinology

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

Evidence of Primary Aldosteronism in a Predominantly Female Cohort of Normotensive Individuals: A Very High Odds Ratio for Progression into Arterial Hypertension

(2013) Athina Markou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis

(2013) Nancy J. Brown   Nature Reviews Nephrology